These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 8679942

  • 1. Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioactive peptides from the C-terminus of human C5a anaphylatoxin.
    Ni F, Carpenter KA, Ripoll DR, Sanderson SD, Hugli TE.
    Biopolymers; 1996 Jan; 38(1):31-41. PubMed ID: 8679942
    [Abstract] [Full Text] [Related]

  • 2. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK, Finch AM, Pierens GK, Craik DJ, Taylor SM, Fairlie DP.
    J Med Chem; 1998 Aug 27; 41(18):3417-25. PubMed ID: 9719594
    [Abstract] [Full Text] [Related]

  • 3. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.
    Kola A, Baensch M, Bautsch W, Hennecke M, Klos A, Casaretto M, Köhl J.
    Immunotechnology; 1996 Jun 27; 2(2):115-26. PubMed ID: 9373320
    [Abstract] [Full Text] [Related]

  • 4. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
    Chen Z, Zhang X, Gonnella NC, Pellas TC, Boyar WC, Ni F.
    J Biol Chem; 1998 Apr 24; 273(17):10411-9. PubMed ID: 9553099
    [Abstract] [Full Text] [Related]

  • 5. Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone.
    Chen Z, Xu P, Barbier JR, Willick G, Ni F.
    Biochemistry; 2000 Oct 24; 39(42):12766-77. PubMed ID: 11041841
    [Abstract] [Full Text] [Related]

  • 6. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
    Bubeck P, Grötzinger J, Winkler M, Köhl J, Wollmer A, Klos A, Bautsch W.
    Eur J Biochem; 1994 Feb 01; 219(3):897-904. PubMed ID: 8112341
    [Abstract] [Full Text] [Related]

  • 7. Alpha helix capping in synthetic model peptides by reciprocal side chain-main chain interactions: evidence for an N terminal "capping box".
    Zhou HX, Lyu P, Wemmer DE, Kallenbach NR.
    Proteins; 1994 Jan 01; 18(1):1-7. PubMed ID: 8146119
    [Abstract] [Full Text] [Related]

  • 8. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
    Monk PN, Barker MD, Partridge LJ, Pease JE.
    J Biol Chem; 1995 Jul 14; 270(28):16625-9. PubMed ID: 7622471
    [Abstract] [Full Text] [Related]

  • 9. Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation.
    Vogen SM, Paczkowski NJ, Kirnarsky L, Short A, Whitmore JB, Sherman SA, Taylor SM, Sanderson SD.
    Int Immunopharmacol; 2001 Nov 14; 1(12):2151-62. PubMed ID: 11710544
    [Abstract] [Full Text] [Related]

  • 10. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C terminus of myohemerythrin.
    Reymond MT, Huo S, Duggan B, Wright PE, Dyson HJ.
    Biochemistry; 1997 Apr 29; 36(17):5234-44. PubMed ID: 9136885
    [Abstract] [Full Text] [Related]

  • 11. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
    Finch AM, Vogen SM, Sherman SA, Kirnarsky L, Taylor SM, Sanderson SD.
    J Med Chem; 1997 Mar 14; 40(6):877-84. PubMed ID: 9083476
    [Abstract] [Full Text] [Related]

  • 12. Identification of a receptor-binding region in the core segment of the human anaphylatoxin C5a.
    Vlattas I, Sytwu II, Dellureficio J, Stanton J, Braunwalder AF, Galakatos N, Kramer R, Seligmann B, Sills MA, Wasvary J.
    J Med Chem; 1994 Aug 19; 37(17):2783-90. PubMed ID: 8064805
    [Abstract] [Full Text] [Related]

  • 13. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.
    Crass T, Bautsch W, Cain SA, Pease JE, Monk PN.
    Biochemistry; 1999 Jul 27; 38(30):9712-7. PubMed ID: 10423250
    [Abstract] [Full Text] [Related]

  • 14. Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains.
    Carpenter KA, Schmidt R, von Mentzer B, Haglund U, Roberts E, Walpole C.
    Biochemistry; 2001 Jul 27; 40(28):8317-25. PubMed ID: 11444978
    [Abstract] [Full Text] [Related]

  • 15. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.
    Finch AM, Wong AK, Paczkowski NJ, Wadi SK, Craik DJ, Fairlie DP, Taylor SM.
    J Med Chem; 1999 Jun 03; 42(11):1965-74. PubMed ID: 10354404
    [Abstract] [Full Text] [Related]

  • 16. Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory activities.
    Sanderson SD, Kirnarsky L, Sherman SA, Ember JA, Finch AM, Taylor SM.
    J Med Chem; 1994 Sep 16; 37(19):3171-80. PubMed ID: 7932541
    [Abstract] [Full Text] [Related]

  • 17. NMR analysis of a potent decapeptide agonist of human C5a anaphylatoxin.
    Vogen SM, Prakash O, Kirnarsky L, Sanderson SD, Sherman SA.
    J Pept Res; 1998 Mar 16; 51(3):226-34. PubMed ID: 9531426
    [Abstract] [Full Text] [Related]

  • 18. C5aR ligand peptide 3D QSAR study performed with an applied linear conformation.
    Anderson CY, Kellogg GE, Freer RJ.
    J Pept Res; 1997 Jun 16; 49(6):476-83. PubMed ID: 9266474
    [Abstract] [Full Text] [Related]

  • 19. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.
    Zhang X, Boyar W, Galakatos N, Gonnella NC.
    Protein Sci; 1997 Jan 16; 6(1):65-72. PubMed ID: 9007977
    [Abstract] [Full Text] [Related]

  • 20. Decapeptide agonists of human C5a: the relationship between conformation and neutrophil response.
    Sanderson SD, Kirnarsky L, Sherman SA, Vogen SM, Prakash O, Ember JA, Finch AM, Taylor SM.
    J Med Chem; 1995 Sep 01; 38(18):3669-75. PubMed ID: 7658455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.